EHS
EHS

Castle Biosciences Presents New Data Demonstrating DecisionDx®-SCC Complements Current Risk Assessment Methods in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck




FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #AHNS–Castle Biosciences announced a podium presentation at the American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer.

Source link

EHS
Back to top button